ES2134808T3 - Compuestos antivirales oralmente activos. - Google Patents

Compuestos antivirales oralmente activos.

Info

Publication number
ES2134808T3
ES2134808T3 ES92913416T ES92913416T ES2134808T3 ES 2134808 T3 ES2134808 T3 ES 2134808T3 ES 92913416 T ES92913416 T ES 92913416T ES 92913416 T ES92913416 T ES 92913416T ES 2134808 T3 ES2134808 T3 ES 2134808T3
Authority
ES
Spain
Prior art keywords
alkyl
compounds
halogen
substituted
orively
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92913416T
Other languages
English (en)
Inventor
Viyyoor M Girijavallabhan
Ashit K Ganguly
Richard W Versace
Anil K Saksena
Patrick A Pinto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2134808T3 publication Critical patent/ES2134808T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)

Abstract

SE PRESENTA UN COMPUESTO REPRESENTADO POR LA FORMULA (I) AR1-O-M-OAR2 EN DONDE AR1 Y AR2 SON INDEPENDIENTEMENTE FENIL SUSTITUIDO O PIRIDINIL SUSTITUIDO, LOS SUSTITUYENTES SOBRE DICHO FENIL O PIRIDINIL SE SELECCIONAN INDEPENDIENTEMENTE ENTRE 1, 2 O 3 DE ALCOXIDO C1-C10, ALQUIL C1-C10, HALOGENO, CARBAMIL, DIALQUILCARBAMIL, ALCOXICARBONIL C1-C10, OXAZOIL, Y ALQUIL C1-C10 SUSTITUIDO POR HALOGENO, ALCOXIDO C1-C10, HIDROXIDO O ALCOXICARBONIL C1-C10; M ES M-1, M-2, M-3 O M-4, ALQUILENO C4-C8, ALQUENILENO C4-C8 O ALQUINILENO C4-C8; O ES OXIGENO; R'' ES ALQUIL C1-C3 O H; A ES OXIGENO O SULFURO; Q SE SELECCIONA ENTRE HIDROGENO, HALOGENO, NITRO, ALQUIL C1-C6, PERHALOALQUIL C1-C6, ALQUILTIO C1-C6, ALQUILSULFONIL C1-C6; LAS LINEAS PUNTEADAS EN M-3 Y M-4 ENTRE LOS CARBONOS 2 Y 3, 3 Y 4, Y 4 Y 5 SIGNIFICAN LOS ENLACES ENTRE LOS CARBONOS 2 Y 3, Y 3 Y 4, Y 5 Y 6, CADA UNO DE ELLOS PUEDE SER UN ENLACE SIMPLE O UN DOBLE ENLACE; N = 1 O 2, M = 1 O 2, P = 0 O 1; TAMBIEN SE PRESENTAN LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS COMPUESTOS ASI COMO COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS Y EL USO DE LOS COMPUESTOS DE LA FORMULA (I) PARA LA PREPARACION DE MEDICAMENTOS PARA METODOS PARA TRATAR O PREVENIR INFECCIONES VIRALES.
ES92913416T 1991-06-19 1992-06-17 Compuestos antivirales oralmente activos. Expired - Lifetime ES2134808T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71745191A 1991-06-19 1991-06-19

Publications (1)

Publication Number Publication Date
ES2134808T3 true ES2134808T3 (es) 1999-10-16

Family

ID=24882086

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92913416T Expired - Lifetime ES2134808T3 (es) 1991-06-19 1992-06-17 Compuestos antivirales oralmente activos.

Country Status (23)

Country Link
US (4) US5559133A (es)
EP (2) EP0519702A1 (es)
JP (1) JP2625258B2 (es)
KR (1) KR960004887B1 (es)
AT (1) ATE182874T1 (es)
AU (1) AU674657B2 (es)
CA (1) CA2111854C (es)
CZ (1) CZ279793A3 (es)
DE (1) DE69229733T2 (es)
ES (1) ES2134808T3 (es)
FI (1) FI935690A0 (es)
IE (1) IE921971A1 (es)
IL (1) IL102241A0 (es)
MX (1) MX9203068A (es)
MY (1) MY107993A (es)
NZ (1) NZ243180A (es)
OA (1) OA09828A (es)
PL (1) PL169699B1 (es)
SK (1) SK144293A3 (es)
TW (1) TW260658B (es)
WO (1) WO1992022520A1 (es)
YU (1) YU63392A (es)
ZA (1) ZA924445B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134808T3 (es) * 1991-06-19 1999-10-16 Schering Corp Compuestos antivirales oralmente activos.
EP0686032A1 (en) * 1993-02-26 1995-12-13 Schering Corporation Use of 2-chloro-1- 4- (2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans
US5958983A (en) * 1997-04-10 1999-09-28 Pharmacia & Upjohn Company Polyaromatic antiviral compositions
WO2001009118A2 (en) * 1999-07-29 2001-02-08 Patrick T Prendergast Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418571A1 (de) * 1973-04-18 1974-11-14 Ciba Geigy Ag Phenyl-aralkyl-aether, diphenyle und benzophenone, verfahren zu ihrer herstellung und ihre verwendung
JPS509785A (es) * 1973-05-31 1975-01-31
JPS5922697B2 (ja) * 1976-01-13 1984-05-28 エーザイ株式会社 ビス−（メタ−アミジノフエノキシ）−化合物
JPS5651423A (en) * 1979-09-13 1981-05-09 Wellcome Found Antiviral agent
DE3362750D1 (en) * 1982-01-29 1986-05-07 Toray Industries Process for preparing alpha,omega-bis(2-chlorophenoxy)-alkane-4,4'-dicarboxylic acid or its lower alkyl ester
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
JPH0621083B2 (ja) * 1986-12-22 1994-03-23 株式会社三光開発科学研究所 ジ（アリ−ルオキシ）アルカンの製造方法
US4891449A (en) * 1988-06-30 1990-01-02 Great Lakes Chemical Corporation Halogenated unsymmetrical higher alkyl phenoxy alkanes
KR920701167A (ko) * 1989-07-07 1992-08-11 에릭 에스. 딕커 약제학적 활성 화합물
ES2134808T3 (es) * 1991-06-19 1999-10-16 Schering Corp Compuestos antivirales oralmente activos.

Also Published As

Publication number Publication date
FI935690A (fi) 1993-12-17
CZ279793A3 (en) 1994-05-18
YU63392A (sh) 1994-11-15
JP2625258B2 (ja) 1997-07-02
CA2111854A1 (en) 1992-12-23
NZ243180A (en) 1995-08-28
US5350772A (en) 1994-09-27
JPH06503839A (ja) 1994-04-28
AU2221392A (en) 1993-01-12
CA2111854C (en) 2001-01-09
SK144293A3 (en) 1994-06-08
US5559133A (en) 1996-09-24
AU674657B2 (en) 1997-01-09
ATE182874T1 (de) 1999-08-15
KR960004887B1 (ko) 1996-04-16
US5449782A (en) 1995-09-12
MY107993A (en) 1996-07-15
TW260658B (es) 1995-10-21
PL169699B1 (en) 1996-08-30
EP0519702A1 (en) 1992-12-23
IL102241A0 (en) 1993-01-14
ZA924445B (en) 1993-02-24
MX9203068A (es) 1993-07-01
FI935690A0 (fi) 1993-12-17
IE921971A1 (en) 1992-12-30
OA09828A (en) 1994-04-15
US5618849A (en) 1997-04-08
EP0590026B1 (en) 1999-08-04
DE69229733T2 (de) 1999-12-02
WO1992022520A1 (en) 1992-12-23
EP0590026A1 (en) 1994-04-06
DE69229733D1 (de) 1999-09-09

Similar Documents

Publication Publication Date Title
KR950000676A (ko) 신규 설포닐아미노 피리미딘
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2117249T3 (es) Derivados de 2,6-diaminopurina.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
PT97710A (pt) Processo para a preparacao de novos derivados da amino-piperidina,da amino-pirrolidina e de amino-per-hidroazepina
ES2037752T3 (es) Utilizacion de un derivado de benzoxazol y su procedimiento de preparacion.
ES2101223T3 (es) Composicion de aciete de refrigerador para refrigerante de fluoroalcano.
DE3468024D1 (de) Benzofuran- and benzopyran-carboxamide derivatives
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2169248T3 (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
MX9304579A (es) Derivados de 4-aza-5alfa-androstan-3-ona 17beta-substituidos, fluorados, proceso para su preparaciony composicion farmaceutica que los comprende.
ZA902633B (en) New sulphonamides derived from benzo-cyclic or benzo heterocyclic acids,their preparation and their application in therapy
ES2045044T3 (es) Derivados de sulfonamidolfenilo y agentes terapeuticos y preventivos de la arritmia que contienen los mismos.
AR241017A2 (es) "procedimiento para la preparacion de fenil-silfonil-oxi-bencimidazol-carbamatos sustituidos."
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES2045126T3 (es) Agentes terapeuticos.
ES8304076A1 (es) "procedimiento de preparacion de compuestos del tipo arilbencensulfonamida".
ES2134808T3 (es) Compuestos antivirales oralmente activos.
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
CO4970714A1 (es) Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
ES2054811T3 (es) Derivados de tetrahidroisoquinolin-2-ilo como antagonistas de tromboxano a2.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2032217T3 (es) Nuevos derivados n-(23-vinblastinoil del acido 1-amino-metilfosfonico, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 590026

Country of ref document: ES